GI
MDGL icon

GAMMA Investing’s Madrigal Pharmaceuticals MDGL Stock Holding History

GAMMA Investing’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$141K Buy
279
+107
+62% +$56.5K ﹤0.01% 1597
2026
Q2 		$92.4K Buy
172
+45
+35% +$23.1K ﹤0.01% 1868
2026
Q1 		$66.5K Sell
127
-11
-8% -$5.25K ﹤0.01% 1978
2025
Q4 		$80.4K Buy
138
+48
+53% +$24.5K ﹤0.01% 1734
2025
Q3 		$41.3K Buy
90
+48
+114% +$17.9K ﹤0.01% 2119
2025
Q2 		$12.7K Sell
42
-76
-64% -$22.6K ﹤0.01% 2684
2025
Q1 		$39.1K Buy
118
+67
+131% +$22K ﹤0.01% 1967
2024
Q4 		$15.7K Buy
51
+25
+96% +$7.03K ﹤0.01% 2386
2024
Q3 		$5.52K Buy
26
+14
+117% +$3.58K ﹤0.01% 2710
2024
Q2 		$3.36K Hold
12
– – ﹤0.01% 2714
2024
Q1 		$3.2K Buy
12
+4
+50% +$942 ﹤0.01% 2581
2023
Q4 		$1.73K Buy
+8
New +$1.4K ﹤0.01% 2617

Other funds holding MDGL

FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
CA
CoreCap Advisors Southfield, Michigan $3.48B AUM 21.43% 1-Year Est. Return
EB
Eastern Bank Boston, Massachusetts $6.58B AUM 23.57% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
TFA
Toth Financial Advisory Leesburg, Virginia $1B AUM 19.18% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
CI
CX Institutional Auburn, Indiana $3.69B AUM 15.82% 1-Year Est. Return

GAMMA Investing's MDGL Position: Q3 2026 in Review

GAMMA Investing increased its Madrigal Pharmaceuticals (MDGL) stake by 62% in Q3 2026, buying an estimated $56.5K and bringing the position to 279 shares worth $141K. The position accounts for ﹤0.01% of the portfolio, ranked #1597.

GAMMA Investing first reported a position in MDGL in Q4 2023 and has held it in 12 quarters since. 8 funds tracked by Wall St. Rank hold MDGL as of Q3 2026.

  • GAMMA Investing held 279 shares of Madrigal Pharmaceuticals worth $141K as of Q3 2026.
  • GAMMA Investing bought 107 Madrigal Pharmaceuticals shares in Q3 2026, an estimated $56.5K.
  • Madrigal Pharmaceuticals made up ﹤0.01% of GAMMA Investing's portfolio in Q3 2026, its #1597 holding.
  • GAMMA Investing first reported a position in Madrigal Pharmaceuticals in Q4 2023 and has held it in 12 quarters since.
  • 8 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.